Stockreport

Biodesix Announces Third Quarter 2024 Results and Highlights

Biodesix, Inc.  (BDSX) 
PDF Q3 2024 revenue grew 35% over Q3 2023 to $18.2 million; Q3 2024 gross profit margin of 77.0%, up from 76.1% in Q3 2023; Q3 2024 Net loss improved by 6% compared to Q3 [Read more]